These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29052160)

  • 1. The Use of Mapping to Estimate Health State Utility Values.
    Ara R; Rowen D; Mukuria C
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):57-66. PubMed ID: 29052160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating Health State Utility Values for Comorbidities.
    Ara R; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):89-94. PubMed ID: 29052158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using health state utility values in models exploring the cost-effectiveness of health technologies.
    Ara R; Wailoo A
    Value Health; 2012; 15(6):971-4. PubMed ID: 22999149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Health State Utility Values in Decision Models.
    Ara R; Brazier J; Zouraq IA
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):77-88. PubMed ID: 29052163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.
    Wailoo AJ; Hernandez-Alava M; Manca A; Mejia A; Ray J; Crawford B; Botteman M; Busschbach J
    Value Health; 2017 Jan; 20(1):18-27. PubMed ID: 28212961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.
    Mukuria C; Rowen D; Harnan S; Rawdin A; Wong R; Ara R; Brazier J
    Appl Health Econ Health Policy; 2019 Jun; 17(3):295-313. PubMed ID: 30945127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    Peasgood T; Brazier J
    Pharmacoeconomics; 2015 Nov; 33(11):1101-5. PubMed ID: 26133293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).
    Goodwin E; Hawton A; Green C
    Health Qual Life Outcomes; 2019 Aug; 17(1):136. PubMed ID: 31382960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.
    Wong CK; Lam CL; Rowen D; McGhee SM; Ma KP; Law WL; Poon JT; Chan P; Kwong DL; Tsang J
    Value Health; 2012 May; 15(3):495-503. PubMed ID: 22583460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
    Paisley S
    Pharmacoeconomics; 2016 Jun; 34(6):597-608. PubMed ID: 26861793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS
    Dewitt B; Feeny D; Fischhoff B; Cella D; Hays RD; Hess R; Pilkonis PA; Revicki DA; Roberts MS; Tsevat J; Yu L; Hanmer J
    Med Decis Making; 2018 Aug; 38(6):683-698. PubMed ID: 29944456
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.